‘SLOW’ TO ACT: Baby formula shortage: FDA chief admits federal regulators were ‘too slow’ to act
FORMULA VS BREASTFEEDING: Why can’t some infants breastfeed during the formula shortage? What health experts want you to know
In February, Abbott introduced a recall of three powdered formulation, halted manufacturing and closed the plant whereas the FDA investigated. The company discovered bacterial strains contained in the plant, however bacterial strains discovered on the facility did not match the 2 out there samples from the infants. Nevertheless, the micro organism they discovered was troubling sufficient to warrant the shuttering of the ability.
Comments
0 comments